Drug data last refreshed 2d ago · AI intelligence enriched 2w ago
Halothane is a volatile halogenated hydrocarbon anesthetic administered by inhalation for general anesthesia induction and maintenance. It has been a foundational inhalational anesthetic since 1958, used primarily in operating rooms and acute care settings. The drug's mechanism involves depression of the central nervous system, though specific neuronal targets remain incompletely characterized.
Brand faces moderate competitive pressure (30%) and approaching loss of exclusivity, signaling contraction in team size and shift toward maintenance rather than growth initiatives.
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Halothane represents a late-stage product with minimal linked job openings, indicating limited career growth trajectory and team expansion. Professionals joining this product should expect focus on cost optimization, regulatory compliance, and market sustainability rather than innovation and market expansion.
Worked on FLUOTHANE at Thayer Medical? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.